Murphy, M.E.; Wills, G.H.; Murthy, S.; Louw, Cheryl; BAteson, A.L.C.; Hunt, R.D.; McHugh, T.D.; Nunn, A.J.; Meredith, S.K.; Mendel, C.M.; Spigelman, M.; Crook, A.M.; Gillespie, S.H.; REMoxTB consortium
(BMC, 2018-10-17)
BACKGROUND : In the REMoxTB study of 4-month treatment-shortening regimens containing moxifloxacin
compared to the standard 6-month regimen for tuberculosis, the proportion of unfavourable outcomes for
women was similar ...